CA2178430C - Surveillance hemodynamique de conductivite differentielle - Google Patents

Surveillance hemodynamique de conductivite differentielle Download PDF

Info

Publication number: CA2178430C
Authority: CA; Canada
Prior art keywords: conductivity; fluid; electrical; cell; sensing
Prior art date: 1995-06-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA 2178430

Other languages

English (en)

Other versions

CA2178430A1 (fr

Inventor

James M. Brugger

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Gambro Renal Products Inc

Original Assignee

Cobe Laboratories Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-07

Filing date

1996-06-06

Publication date

2000-05-23

1995-06-07 Priority claimed from US08/486,982 external-priority patent/US5644240A/en

1996-06-06 Application filed by Cobe Laboratories Inc filed Critical Cobe Laboratories Inc

1996-12-08 Publication of CA2178430A1 publication Critical patent/CA2178430A1/fr

2000-05-23 Application granted granted Critical

2000-05-23 Publication of CA2178430C publication Critical patent/CA2178430C/fr

2016-06-06 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

230000000004 hemodynamic effect Effects 0.000 title description 12
239000012530 fluid Substances 0.000 claims abstract description 160
150000002500 ions Chemical class 0.000 claims description 31
238000011144 upstream manufacturing Methods 0.000 claims description 28
238000000034 method Methods 0.000 claims description 27
230000001939 inductive effect Effects 0.000 claims description 17
239000003550 marker Substances 0.000 claims description 10
230000005674 electromagnetic induction Effects 0.000 claims description 8
230000000694 effects Effects 0.000 claims description 7
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 8
239000011780 sodium chloride Substances 0.000 abstract description 7
238000002347 injection Methods 0.000 abstract 1
239000007924 injection Substances 0.000 abstract 1
210000004027 cell Anatomy 0.000 description 97
210000004369 blood Anatomy 0.000 description 67
239000008280 blood Substances 0.000 description 67
238000000502 dialysis Methods 0.000 description 28
206010016717 Fistula Diseases 0.000 description 24
230000003890 fistula Effects 0.000 description 24
230000005284 excitation Effects 0.000 description 20
238000012360 testing method Methods 0.000 description 14
238000005259 measurement Methods 0.000 description 7
230000007423 decrease Effects 0.000 description 6
230000001965 increasing effect Effects 0.000 description 5
210000001367 artery Anatomy 0.000 description 4
238000012544 monitoring process Methods 0.000 description 4
210000003462 vein Anatomy 0.000 description 4
230000009471 action Effects 0.000 description 3
230000004087 circulation Effects 0.000 description 3
238000010586 diagram Methods 0.000 description 3
238000007373 indentation Methods 0.000 description 3
230000003287 optical effect Effects 0.000 description 3
230000003134 recirculating effect Effects 0.000 description 3
230000008901 benefit Effects 0.000 description 2
230000017531 blood circulation Effects 0.000 description 2
DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
238000001631 haemodialysis Methods 0.000 description 2
230000000322 hemodialysis Effects 0.000 description 2
239000007788 liquid Substances 0.000 description 2
239000012528 membrane Substances 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
230000000007 visual effect Effects 0.000 description 2
206010003226 Arteriovenous fistula Diseases 0.000 description 1
101100290380 Caenorhabditis elegans cel-1 gene Proteins 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
210000001557 animal structure Anatomy 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
238000004422 calculation algorithm Methods 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
229940109239 creatinine Drugs 0.000 description 1
238000012864 cross contamination Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
239000000076 hypertonic saline solution Substances 0.000 description 1
239000012535 impurity Substances 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
239000004973 liquid crystal related substance Substances 0.000 description 1
230000013011 mating Effects 0.000 description 1
238000012806 monitoring device Methods 0.000 description 1
230000002572 peristaltic effect Effects 0.000 description 1
235000012434 pretzels Nutrition 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
239000004404 sodium propyl p-hydroxybenzoate Substances 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
230000001256 tonic effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1

Landscapes

Measuring Volume Flow (AREA)
Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
External Artificial Organs (AREA)

CA 2178430 1995-06-07 1996-06-06 Surveillance hemodynamique de conductivite differentielle Expired - Fee Related CA2178430C (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/486,982 US5644240A (en)	1992-09-30	1995-06-07	Differential conductivity hemodynamic monitor
US08/486,982		1995-06-07

Publications (2)

Publication Number	Publication Date
CA2178430A1 CA2178430A1 (fr)	1996-12-08
CA2178430C true CA2178430C (fr)	2000-05-23

Family

ID=23933912

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2178430 Expired - Fee Related CA2178430C (fr)	1995-06-07	1996-06-06	Surveillance hemodynamique de conductivite differentielle

Country Status (1)

Country	Link
CA (1)	CA2178430C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9702074D0 (sv)	1997-06-02	1997-06-02	Gambro Ab	Method and device for calculating dialysis efficiency

1996
- 1996-06-06 CA CA 2178430 patent/CA2178430C/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2178430A1 (fr)	1996-12-08

Legal Events

Date	Code	Title	Description
1997-01-28	EEER	Examination request
2011-06-06	MKLA	Lapsed

Publication	Publication Date	Title
US5644240A (en)	1997-07-01	Differential conductivity hemodynamic monitor
EP0590810B1 (fr)	1998-07-15	ContrÔleur de recirculation utilisant la mesure différentielle de la conductibilité
US5631552A (en)	1997-05-20	Hemodynamic monitor for detecting air bubbles
US6210591B1 (en)	2001-04-03	Method to measure blood flow rate in hemodialysis shunts
US7815852B2 (en)	2010-10-19	Method, apparatus and software program for measurement of a parameter relating to a heart-lung system of a mammal
US7297280B2 (en)	2007-11-20	Method and apparatus to measure blood flow in hemodialysis shunts
EP2253344B1 (fr)	2017-06-07	Système de déconnection d'accès
EP0781161A1 (fr)	1997-07-02	Methode de mesure du debit sanguin dans les pontages en hemodialyse
JP2001506140A (ja)	2001-05-15	音速希釈による心臓血管測定
US6061590A (en)	2000-05-09	Method and apparatus for predicting intradialytic morbid events through the monitoring of a central blood volume
JP3622984B2 (ja)	2005-02-23	血液透析シャント内の血行動態の不侵襲測定システム
Lindsay et al.	1996	A device and a method for rapid and accurate measurement of access recirculation during hemodialysis
CA2178430C (fr)	2000-05-23	Surveillance hemodynamique de conductivite differentielle
Lindsay et al.	1999	Monitoring vascular access flow
CA2178468C (fr)	2000-09-05	Surveillance hemodynamique de conductivite differentielle
CA2222248C (fr)	1999-06-29	Jeu de tubes concu pour etre utilise dans un appareil servant a determiner le degre de recirculation d'un fluide
Lopot et al.	2004	Vascular access monitoring: methods and procedures–something to standardize?
CN101920049A (zh)	2010-12-22	测定透析通路的再循环率和/或再循环量的方法及系统
Schneditz et al.	2004	Vascular Access Recirculation: Measurement and Clinical
Válek	2005	Vascular Access Monitoring